Session Chair Profile

Ph.D., Principal Scientist, Cancer Immunology, Genentech

Sascha Rutz is a Principal Scientist in the Cancer Immunology Department at Genentech. He is the Research Lead for the T Cell Therapy program in Oncology at Genentech, focused on developing TCR-engineered T cells targeting neoantigens in solid tumors. Sascha is a T cell immunologist by training, and received his Ph.D. from Humboldt University Berlin, Germany, before joining Genentech as a Postdoc in 2009.

 Session Abstract – PMWC 2022 Silicon Valley